An Act to renumber 632.895 (8) (a) 1.; to renumber and amend 632.895 (8) (d); to amend 40.51 (8m), 66.0137 (4), 120.13 (2) (g) and 609.80; to create 49.46 (2) (b) 6. n., 632.895 (8) (a) 1b., 632.895 (8) (a) 1f., 632.895 (8) (a) 1k., 632.895 (8) (a) 1p., 632.895 (8) (a) 1s., 632.895 (8) (a) 1w., 632.895 (8) (a) 5., 632.895 (8) (a) 6., 632.895 (8) (am), 632.895 (8) (d) 2. and 632.895 (8) (d) 3. of the statutes; Relating to: coverage of breast cancer screenings by the Medical Assistance program and health insurance policies and plans. (FE)
SB264 expands insurance and Medicaid coverage for breast cancer-related imaging and screening services. It requires disability insurance policies, self-insured health plans, and the state Medical Assistance program to cover diagnostic breast examinations and supplemental breast screening examinations for people at increased risk of breast cancer or who have heterogeneously or extremely dense breast tissue. The bill defines several imaging modalities covered under these terms, including breast MRI, ultrasound, tomosynthesis, contrast-enhanced mammography, and diagnostic mammography, and ties some coverage determinations to current National Comprehensive Cancer Network guidelines and American College of Radiology density standards.
The bill also updates existing mammogram coverage law without eliminating current screening requirements. It clarifies that preferred provider plans and defined network plans are subject to the breast screening coverage rules, and it adds explicit statutory definitions for the relevant imaging procedures and plan types. The bill generally prohibits cost-sharing for diagnostic and supplemental breast screenings, while preserving an exception where federal health savings account rules would otherwise be affected for high-deductible plans.
In terms of state law, SB264 amends multiple insurance and public benefits provisions, including statutes governing the group insurance board, municipal and school self-insured plans, and Medicaid reimbursement. It creates new statutory language in the breast cancer screening section of the insurance code, adds a Medicaid coverage item, and makes conforming changes to related sections so that public employee plans and certain local government plans must comply with the new coverage requirements. The bill is designed to take effect a few months after publication, with delayed applicability for policies or plans affected by collective bargaining agreements.
The overall sentiment around the bill appears strongly favorable. It passed the Senate 32-1 and the Assembly 96-0, indicating broad bipartisan support and little recorded opposition. The bill’s framing as a breast cancer early-detection measure, especially for people with dense breast tissue or elevated risk, likely contributed to the strong consensus.
The main point of contention is limited and technical rather than ideological. The bill’s no-cost-sharing requirement could affect plan design and premiums, and the text notes that it may constitute a health insurance mandate requiring a social and financial impact report. Another technical issue is the interaction with federal HSA-qualified high-deductible health plans, which the bill addresses by preserving federal tax-advantaged status where necessary.
SB264 would expand mandatory coverage under Wisconsin insurance law and Medical Assistance for breast cancer diagnostic and supplemental screening services, affecting private disability insurance policies, self-insured governmental health plans, Medicaid, and related public employee coverage statutes. It adds new definitions and coverage requirements to s. 632.895 (8), requires no cost-sharing for the covered screenings except where federal HSA rules require otherwise, and makes conforming amendments to statutes governing state, municipal, and school district health plans.
The bill appears to have received very strong support. It passed the Senate 32-1 and the Assembly 96-0, suggesting broad bipartisan agreement on the policy goal of improving access to breast cancer screening and early detection. No committee transcript was provided, but the voting record indicates minimal opposition and a generally favorable legislative climate.
The principal areas of concern are technical and fiscal rather than political. The bill may be treated as a health insurance mandate, which can trigger a required social and financial impact report and raise questions about premium effects and plan costs. There is also a specific federal compliance issue for health-savings-account-qualified high-deductible plans, since the bill preserves HSA eligibility by delaying the no-cost-sharing rule until the deductible is met when required by federal law. Any opposition appears to have been limited, given the near-unanimous votes.